Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Total Current Liabilities (2022 - 2023)

Historic Total Current Liabilities for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to $12.5 million.

  • Therapeutics' Total Current Liabilities fell 729.81% to $12.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.5 million, marking a year-over-year decrease of 729.81%. This contributed to the annual value of $13.0 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Therapeutics reported Total Current Liabilities of $12.5 million as of Q3 2023, which was down 729.81% from $12.3 million recorded in Q2 2023.
  • Over the past 5 years, Therapeutics' Total Current Liabilities peaked at $14.3 million during Q1 2023, and registered a low of $12.1 million during Q2 2022.